Martin McCarter is an Oncology physician affiliated with University of Colorado Cancer Center. OpenAlex indexes 673 publications with 14,845 citations (h-index 63); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Surgical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Registry record last updated 26 Aug 2016.
Clinical trials
- Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
Sponsor: University of Colorado, Denver
- Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Sponsor: University of Colorado, Denver
- Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Iovance Biotherapeutics, Inc.Program year20255 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Aadi Bioscience, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2015–2021 per NIH RePORTER. The latest:
- Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome
University of Colorado Denver
FY2021$218,089R21CA245432 - Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome
University of Colorado Denver
FY2020$181,741R21CA245432 - Combined ATRA and ipilimumab treatment to reduce immunosuppression in melanoma patients
University of Colorado Denver
FY2016$169,106R21CA187497
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Antonio Jimeno, MD
University of Colorado Cancer Center
Wells Messersmith, MD
University of Colorado Cancer Center
Manali Kamdar, MD
University of Colorado Cancer Center
Richard Schulick, MD, MBA
University of Colorado Cancer Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”